BE709012A - - Google Patents

Info

Publication number
BE709012A
BE709012A BE709012DA BE709012A BE 709012 A BE709012 A BE 709012A BE 709012D A BE709012D A BE 709012DA BE 709012 A BE709012 A BE 709012A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE709012A publication Critical patent/BE709012A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE709012D 1967-01-10 1968-01-05 BE709012A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR90478A FR6087M (ja) 1967-01-10 1967-01-10
FR133258A FR6934M (ja) 1967-01-10 1967-12-21

Publications (1)

Publication Number Publication Date
BE709012A true BE709012A (ja) 1968-05-16

Family

ID=26174501

Family Applications (1)

Application Number Title Priority Date Filing Date
BE709012D BE709012A (ja) 1967-01-10 1968-01-05

Country Status (13)

Country Link
US (1) US3542870A (ja)
AT (1) AT278750B (ja)
BE (1) BE709012A (ja)
CH (1) CH485658A (ja)
DE (1) DE1668930C3 (ja)
DK (1) DK120400B (ja)
ES (1) ES349044A1 (ja)
FI (1) FI48067C (ja)
FR (2) FR6087M (ja)
GB (1) GB1146139A (ja)
SE (1) SE349020B (ja)
SU (1) SU456406A3 (ja)
YU (1) YU34272B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7689T1 (de) 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
JPS6058927A (ja) * 1983-09-09 1985-04-05 Nippon Mejifuijitsukusu Kk 放射能標識血小板製剤
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
US6650943B1 (en) 2000-04-07 2003-11-18 Advanced Bionics Corporation Fully implantable neurostimulator for cavernous nerve stimulation as a therapy for erectile dysfunction and other sexual dysfunction
US6885895B1 (en) * 2001-04-26 2005-04-26 Advanced Bionics Corporation Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
US20070179181A1 (en) * 2004-03-17 2007-08-02 Baxter Andrew D Treatment of inflammatory disorders and pain using beta-aminoalcohols
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2661372A (en) * 1953-12-01 Pharmacologically valuable stereo
GB789033A (en) * 1954-10-23 1958-01-15 Philips Nv Improvements in or relating to substituted aralkyl-phenyl-alkylamines
FR1165845A (fr) * 1955-05-28 1958-10-29 Philips Nv Amines secondaires portant des substituants et leur préparation
GB800718A (en) * 1955-05-28 1958-09-03 Philips Nv Novel substituted alkylamines and processes for their production
BE630296A (ja) * 1962-03-31
NL130079C (ja) * 1963-06-28
FR3654M (fr) * 1963-11-08 1965-11-02 Raymond Michel β(-3:5 diiodo-4 hydroxyphényl) βhydroxy αméthyl n méthyléthylamine-synthese et a titre d'hypertenseur a action prolongée, son utilisation dans le traitement des collapsus cardiovasculaires.

Also Published As

Publication number Publication date
DK120400B (da) 1971-05-24
SU456406A3 (ru) 1975-01-05
GB1146139A (en) 1969-03-19
ES349044A1 (es) 1969-08-16
CH485658A (fr) 1970-02-15
AT278750B (de) 1970-02-10
FR6934M (ja) 1969-05-05
DE1668930C3 (de) 1974-02-28
FR6087M (ja) 1968-06-04
FI48067C (fi) 1974-06-10
DE1668930B2 (de) 1973-08-02
YU4668A (en) 1978-10-31
US3542870A (en) 1970-11-24
YU34272B (en) 1979-04-30
DE1668930A1 (de) 1971-09-16
FI48067B (ja) 1974-02-28
SE349020B (ja) 1972-09-18

Similar Documents

Publication Publication Date Title
FR6934M (ja)
AU3054676A (ja)
BE711545A (ja)
BE711375A (ja)
BE711082A (ja)
BE711050A (ja)
BE710718A (ja)
BE710572A (ja)
BE710530A (ja)
BE710478A (ja)
BE710425A (ja)
BE710339A (ja)
BE710055A (ja)
BE709862A (ja)
BE709745A (ja)
BE709411A (ja)
BE709270A (ja)
BE709174A (ja)
BE709034A (ja)
BE707071A (ja)
BE706494A (ja)
BE704830A (ja)
BE703155A (ja)
BE703128A (ja)
BE692779A (ja)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: LABORATOIRES HOUDE

Effective date: 19880105